Oscine Therapeutics IVS — Credit Rating and Financial Key Figures
CVR number: 38663062
Ole Maaløes Vej 3, 2200 København N
Income statement (kDKK)
| 2018 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | -1.42 |
| EBIT | -1.42 |
| Pre-tax profit | -1.42 |
| Net earnings | -1.42 |
Assets (kDKK)
| 2017 | 2018 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Holdings in group member companies | 0.00 | |
| Investments total | 0.00 | |
| Long term receivables total | ||
| Inventories total | ||
| Prepayments and accrued income | 0.21 | |
| Short term receivables total | 0.21 | |
| Cash and bank deposits | 7.00 | 7.00 |
| Cash and cash equivalents | 7.00 | 7.00 |
| Balance sheet total (assets) | 7.00 | 7.21 |
Equity and liabilities (kDKK)
| 2017 | 2018 | |
|---|---|---|
| Share capital | 7.00 | 7.00 |
| Profit of the financial year | -1.42 | |
| Shareholders equity total | 7.00 | 5.58 |
| Non-current liabilities total | ||
| Current owed to group member | 0.00 | |
| Other non-interest bearing current liabilities | 1.62 | |
| Current liabilities total | 1.62 | |
| Balance sheet total (liabilities) | 7.00 | 7.21 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.